全文获取类型
收费全文 | 15483篇 |
免费 | 802篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 339篇 |
儿科学 | 341篇 |
妇产科学 | 317篇 |
基础医学 | 2706篇 |
口腔科学 | 348篇 |
临床医学 | 1405篇 |
内科学 | 2576篇 |
皮肤病学 | 400篇 |
神经病学 | 1612篇 |
特种医学 | 888篇 |
外科学 | 2089篇 |
综合类 | 110篇 |
一般理论 | 2篇 |
预防医学 | 781篇 |
眼科学 | 530篇 |
药学 | 1042篇 |
中国医学 | 19篇 |
肿瘤学 | 831篇 |
出版年
2022年 | 94篇 |
2021年 | 170篇 |
2020年 | 111篇 |
2019年 | 189篇 |
2018年 | 249篇 |
2017年 | 189篇 |
2016年 | 301篇 |
2015年 | 303篇 |
2014年 | 357篇 |
2013年 | 452篇 |
2012年 | 854篇 |
2011年 | 784篇 |
2010年 | 511篇 |
2009年 | 513篇 |
2008年 | 700篇 |
2007年 | 807篇 |
2006年 | 851篇 |
2005年 | 873篇 |
2004年 | 808篇 |
2003年 | 711篇 |
2002年 | 761篇 |
2001年 | 351篇 |
2000年 | 287篇 |
1999年 | 287篇 |
1998年 | 214篇 |
1997年 | 178篇 |
1996年 | 156篇 |
1995年 | 134篇 |
1994年 | 111篇 |
1993年 | 106篇 |
1992年 | 146篇 |
1991年 | 156篇 |
1990年 | 157篇 |
1989年 | 158篇 |
1988年 | 156篇 |
1987年 | 121篇 |
1986年 | 107篇 |
1985年 | 127篇 |
1984年 | 119篇 |
1983年 | 87篇 |
1982年 | 73篇 |
1981年 | 86篇 |
1979年 | 112篇 |
1978年 | 82篇 |
1977年 | 89篇 |
1976年 | 78篇 |
1975年 | 78篇 |
1974年 | 85篇 |
1973年 | 74篇 |
1972年 | 83篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
61.
K Brismar M Gutniak G Povoa S Werner K Hall 《Journal of endocrinological investigation》1988,11(8):599-602
The serum levels of the low molecular form of insulin-like growth factor binding protein (IGFBP) was determined in 56 outpatients with diabetes mellitus by a radioimmunoassay developed for amniotic 35 kDa IGFBP. The mean level of 35 kDa IGFBP was found to be threefold higher in insulin dependent diabetes mellitus (IDDM), 112 +/- 13 ng/ml, than in age matched controls, 37 +/- 2 ng/ml, while the mean level in non-insulin dependent diabetes mellitus (NIDDM), 16 +/- 2 ng/ml, was decreased. In hospitalized IDDM patients there was a significant correlation (r = 0.91, p less than 0.01) between fasting blood-glucose and 35 kDa IGFBP levels, not found in NIDDM patients. During insulin infusion the 35 kDa IGFBP levels declined with a half-life of 60-120 min. The decline in IGFBP continued even after the establishment of steady state B-glucose at 4.7 mmol/l. In conclusion, the elevated 35 kDa IGFBP levels in IDDM can be attributed to insulin deficiency and may reflect a reduced bioavailability of the IGFs at the target cells. 相似文献
62.
O. May M.D. H. Kirkegaard Nielsen M. U. Werner 《Acta anaesthesiologica Scandinavica》1988,32(3):239-243
A new and simple acceleration transducer (ACT)–based system of neuromuscular monitoring has recently been introduced. The precision of this transducer has been evaluated as compared to a conventional force displacement transducer (FDT) in the present study. Ten progressions of spontaneous recovery from atracurium–induced block with simultaneous measurements using the ACT on one hand and the FDT on the other were studied. Five individuals undergoing elective surgery in modified neurolept anaesthesia and one ICU–patient requiring prolonged neuromuscular blockade, sedated with pentobarbital, were included. Measurements were carried out on the latter patient on 5 consecutive days. Train–of–four (TOF) stimulation was used, readings were given in twitch heights (TH) (Tl/control value), and when four responses were obtained in TOF–ratios (T4/T1). Linearity was achieved after logit–transformation and the values regressed on time for each progression of recovery. Analysis of variance was applied to the regressions for the TH and TOF–ratio readings of each transducer. No significant differences were found, either between variation due to differences between slopes or variation due to technical error between the two transducers. The study indicates that the ACT is equal to the FDT with regard to precision in clinical recordings on atracuriumrelaxed individuals. 相似文献
63.
64.
Werner Steimer Julia M Potter 《Clinica chimica acta; international journal of clinical chemistry》2002,315(1-2):137-155
BACKGROUND: Pharmacogenetics is the science of the influence of heredity on pharmacological response. ISSUES: The cost of severe adverse drug reactions in individuals has been estimated in the US alone to be in excess of US$4 billion. It has been argued that in a significant proportion of cases, the efficacy and toxicity profiles of drug therapy would be substantially improved in individuals if characteristics due to genetic variation were taken into account. Methods are now available, which make screening for susceptibility feasible. CONCLUSIONS: There are several therapeutic areas in which screening may give rise to significant improvements in outcome with cost-benefits to both the individual and the community. However, there is currently a lack of data on which cost-benefit analysis can be based. The challenge is to provide this information for new drugs, and for drugs with established therapeutic roles. 相似文献
65.
Werner I Hagens Peter Olinga Dirk K F Meijer Geny M M Groothuis Leonie Beljaars Klaas Poelstra 《Liver international》2006,26(2):232-239
BACKGROUND: Liver fibrosis is the common response to chronic liver injury, ultimately leading to cirrhosis. Several lines of evidence indicate that inducing apoptosis of hepatic stellate cells (HSC) may lead to regression of liver fibrosis. Recently, it was shown that gliotoxin (GTX) induces apoptosis of HSC. However, the clinical use of GTX may be limited because of the lack of cell and tissue specificity, causing a high risk of potentially severe adverse effects. The aim of this study, therefore, was to study the effect of GTX on different cells of the liver. METHODS: We used normal and fibrotic precision-cut rat liver slices to study the effect of GTX on the various resident liver cell types. In these slices, the complex cell-cell interactions are preserved, which closely mimics the in vivo situation. RESULTS: GTX exhibited a potent apoptosis-inducing activity in these slices. Both immunohistochemical stainings and real-time mRNA techniques showed that this apoptosis-inducing effect was seen in HSC. However, Kupffer cells and liver endothelial cells were also affected by GTX, whereas hepatocytes were only mildly affected. CONCLUSIONS: This study indicates that the apoptosis-inducing strategy to treat liver fibrosis has high potential, but it will be necessary to develop an HSC-specific therapy to prevent adverse effects. 相似文献
66.
67.
68.
J. Viby Mogensen M.D. Ph.D. E. Jensen M. Werner H. Kirkegaard Nielsen 《Acta anaesthesiologica Scandinavica》1988,32(1):45-48
A new method for monitoring neuromuscular function based on measurement of acceleration is presented. The rationale behind the method is Newton's second law, stating that the acceleration is directly proportional to the force. For measurement of acceleration, a piezo-electric ceramic wafer was used. When this piezo electrode was fixed to the thumb, an electrical signal proportional to the acceleration was produced whenever the thumb moved in response to nerve stimulation. The electrical signal was registered and analysed in a Myograph 2000 neuromuscular transmission monitor. In 35 patients anaesthetized with halothane, train-of-four ratios measured with the accelerometer (ACT-TOF) were compared with simultaneous mechanical train-of-four ratios (FDT-TOF). Control ACT-TOF ratios were significantly higher than control FDT-TOF ratios: 116 +/- 12 and 98 +/- 4 (mean +/- s.d.), respectively. In five patients not given any relaxant during the anaesthetic procedure (20-60 min), both responses were remarkably constant. In 30 patients given vecuronium, a close linear relationship was found during recovery between ACT-TOF and FDT-TOF ratios. It is concluded that the method fulfils the basic requirements for a simple and reliable clinical monitoring tool. 相似文献
69.
Werner Tolksdorf 《Schmerz (Berlin, Germany)》1988,2(2):105
Ohne Zusammenfassung 相似文献
70.